Michael Macmanus

Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study

SP Ng, CE Cardenas, H Bahig, B Elgohari, J Wang, JM Johnson, AC Moreno, SJ Shah, AS Garden, J Phan, GB Gunn, SJ Frank, Y Ding, L Na, Y Yuan, D Urbauer, DI Rosenthal, WH Morrison, MP MacManus, CD Fuller

Conference Proceedings  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography

Michael P MacManus, Michael S Hofman, Rodney J Hicks, Belinda A Campbell, Andrew Wirth, John F Seymour, Nicole Haynes, Kate Burbury

Journal article  |  2020  |  International Journal of Radiation Oncology • Biology • Physics

PURPOSE: Patients with abscopal regressions of lymphoma after palliative involved-site radiation therapy (ISRT), detected on seque..

Total body irradiation in Australia and New Zealand: results of a practice survey

Lotte S Fog, Andrew Wirth, Michael MacManus, Simon Downes, Michael Grace, Alicia Moggre, Koki Mugabe, Gabor Neveri, Lisa Nourbehesht, Vanessa Panettieri, Dane Pope, Lucy Sim, Cameron Stanton, Blair Steer, Allan Stewart, Elena Ungureanu, Tomas Kron

Journal article  |  2020  |  Physical and Engineering Sciences in Medicine

Total body irradiation (TBI) is an important treatment modality for the preparation of patients for bone marrow transplants. It is..

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy

Michael P MacManus, Rodney J Hicks, Mathias Bressel, Belinda A Campbell, Andrew Wirth, Gail Ryan, H Miles Prince, Max Wolf, Rachel Brown, John F Seymour

Journal article  |  2020  |  Cancers

Advanced-stage follicular lymphoma (FL) is generally considered incurable with conventional systemic therapies, but historic serie..

Robust, independent and relevant prognostic F-18-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

Tom Konert, Sarah Everitt, Matthew D La Fontaine, Jeroen B van de Kamer, Michael P MacManus, Wouter V Vogel, Jason Callahan, Jan-Jakob Sonke

Journal article  |  2020  |  PLoS One

In locally advanced lung cancer, established baseline clinical variables show limited prognostic accuracy and 18F-fluorodeoxygluco..

Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancer

Nicholas Bucknell, Nicholas Hardcastle, Price Jackson, Michael Hofman, Jason Callahan, Peter Eu, Amir Iravani, Rhonda Lawrence, Olga Martin, Mathias Bressel, Beverley Woon, Benjamin Blyth, Michael MacManus, Keelan Byrne, Daniel Steinfort, Tomas Kron, Gerard Hanna, David Ball, Shankar Siva

Journal article  |  2020  |  BMJ Open

BACKGROUND: In the curative-intent treatment of locally advanced lung cancer, significant morbidity and mortality can result from ..

Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience

Michael MacManus, Richard De Abreu Lourenco, Fiona Hegi-Johnson

Journal article  |  2019  |  Journal of Thoracic Disease

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua WD Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson, Stephen Bell, Chengetai Dunduru, James Gallo, Erica S Tsang, Xuan Tan, Jonathan Wong, Jessica Pearce, Robert Campbell, Shao Tneh, Sophie Shorten, Melissa Ng, Tara Cochrane, Constantine S Tam, Emad Abro, Eliza Hawkes, et al.

Journal article  |  2019  |  Blood Advances

Management practices in early-stage (I/II) follicular lymphoma (FL) are variable and include radiation (RT), systemic therapy, or ..

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial

T Konert, WV Vogel, D Paez, A Polo, E Fidarova, H Carvalho, PS Duarte, AC Zuliani, AO Santos, D Altuhhova, L Karusoo, R Kapoor, A Sood, J Khader, A Al-Ibraheem, Y Numair, S Abubaker, C Soydal, T Kutuk, TA Le, et al.

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

PURPOSE: Patients with stage III non-small-cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT) in low- and middle-income..

PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment

Amir Iravani, Guy-Anne Turgeon, Tim Akhurst, Jason W Callahan, Mathias Bressel, Sarah J Everitt, Shankar Siva, Michael S Hofman, Rodney J Hicks, David L Ball, Michael P Mac Manus

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging